FCOMV
Foresite Capital Opportunity Management V Portfolio holdings
AUM
$33.3M
This Quarter Return
+35.89%
1 Year Return
-46.98%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$149M
AUM Growth
–
Cap. Flow
+$149M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
$85.6M |
| 2 |
HLTH
Cue Health Inc. Common Stock
HLTH
|
$20.5M |
| 3 |
Quantum-Si Incorporated
QSI
|
$12.6M |
| 4 |
Disc Medicine
IRON
|
$7.09M |
| 5 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$5.95M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $85.6M | 57.37% | +5,227,307 | New | +$85.6M |
|
|
HLTH
2
DELISTED
Cue Health Inc. Common Stock
HLTH
| $20.5M | 13.73% | +1,527,103 | New | +$20.5M |
|
|
3
Quantum-Si Incorporated
QSI
$227M
| $12.6M | 8.43% | +1,598,125 | New | +$12.6M |
|
|
4
Disc Medicine
IRON
$2.07B
| $7.09M | 4.75% | +2,435,125 | New | +$7.09M |
|
|
THRX
5
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $5.95M | 3.99% | +468,820 | New | +$5.95M |
|
6
Cullinan Oncology
CGEM
$445M
| $5.88M | 3.94% | +381,002 | New | +$5.88M |
|
|
KNTE
7
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $5.17M | 3.46% | +291,667 | New | +$5.17M |
|
8
Compass Therapeutics
CMPX
$483M
| $3.49M | 2.34% | +1,100,000 | New | +$3.49M |
|
9
Adicet Bio
ACET
$59.9M
| $2.97M | 1.99% | +170,000 | New | +$2.97M |
|